- The Lancet Pneumology
- 1 comment
Pooled analysis of the SIROCCO and CALIMA studies
Decreased skeletal muscle area is associated with shorter DFS and OS.
Fewer illnesses, briefer symptoms in babies receiving higher dose.
Data reinforce utility of oral corticosteroids in children aged 2-3 years with wheeze.
Earlier studies had yielded conflicting evidence.
Patients who received both treatments were more likely to develop IP.
But combining spirometry with symptom and exacerbation data was predictive.
The therapy could be the first new treatment to improve survival in patients with severe scleroderma in more than four decades.
Data from the phase 3 FLAURA trial.
This is the first randomised controlled trial to investigate the routine use of clinically assisted hydration in cancer patients at the end-of-life.
The launch of the course comes at a time when concerns continue to mount about antimicrobial resistance.
Almost 33% fewer cases among toddlers vs prevaccination era.
Latest statistics from the PHE.
Breathing retraining for asthma | LABAs/LAMAs increase CVD events in COPD.
Parents of paediatric patients may react more negatively to doctors who communicate uncertainty of diagnosis explicitly.